Discovery of antiviral SARS-CoV-2 main protease inhibitors by structure-guided hit-to-lead optimization of carmofur
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (M^(pro)) has been targeted for the development of anti-SARS-CoV-2 agents against COVID-19 infection because M^(pro) processes essential viral polyproteins and plays a key
